Deleted Tweets From Scott Gottlieb, R-D.C.

@megtirrell So @megtirrell thus ends the case control study of fist bumping? Is it back to handshakes at #JPM19 ??

Today @US_FDA announced new guidance for public warnings of recalls. First in a series of policy steps we’ll take this year to further improve recall process. Read more: https://t.co/HzV3hShzUK

RT @FDAOncology: The Patient Engagement Collaborative will bring together the patient community and regulators to discuss patient en… https://t.co/4Xoh9zb8TV

FDA’s compounding policy priorities plan lays out how we'll implement key provisions of DQSA through a series of draft and final guidance documents, proposed and final rules and a revised draft MOU between the FDA and the states: https://t.co/ljI2psUpfj

One step we’re taking is to make it more feasible for certain compounders to become outsourcing facilities by taking a risk-based approach to how we will implement good manufacturing requirements with the goal of making it more practical and lower cost: h

Today, as part of our 2018 plan, FDA also issued three final guidances for compounding: two explaining the agency’s policies on the “essentially a copy” provisions and another on mixing, diluting, or repackaging biological products: https://t.co/ljI2psUpf

Today FDA issued a comprehensive plan for implementing DQSA, balancing access to compounded drugs for patients whose needs cannot be met by FDA-approved products with our obligation to help protect patients from poor quality compounded drugs: https://t.co

1/3 I recognize the consequences of a government shutdown to #FDA employees and their families. To my colleagues: You have my personal commitment that #FDA leadership will do our best to mitigate the impacts of the disruptions and any burdens to you and y

2/3 I join all of #FDA leadership in thanking the dedicated staff at #FDA during this challenging time. Key staff are working very hard this weekend to make sure mission critical, public health work will continue. I am proud to be Commissioner of this Age

3/3 If there's a shutdown Monday, I'll visit with staff at all hands at White Oak as we go through an orderly transition. Much critical work will go on. We're united w/FDA staff in support of an operational #FDA to carry out activities that support critic

I'm grateful for efforts of #FDA colleagues who remain on the job during shutdown to perform critical work to protect public; and I’m committed to do what we can to address hardship on those who find themselves on furlough as a result of lapse in funding

#ShutDown: Critical activities at #FDA related to flu will continue. Latest #FluView report indicates widespread #flu activity across the U.S.; and significant flu activity likely to continue for several more weeks. Updates: https://t.co/74SAHZZbqH

For the latest info on @FDA shutdown plans and our efforts to ensure critical activities continue during the lapse in funding, see https://t.co/xfLVvrHN4b https://t.co/eyOvPptQ3X

I’m in White Oak, MD today at #FDA headquarters. I did not travel to Davos today as previously planned

RT @PharmaPinkSheet: CBER Director Marks: #regenerativemedicine enforcement will be 'notched up' in 2018. Read in full today:… https://t.co/ptQti1ejyM

#FDA recognizes the consequences of government shutdown to public we serve, our employees and their families; thanks all for patience and dedication as legislators worked to restore funding: https://t.co/eul2eBpstA

Our drug shortage team is continuing their mission critical work. We will continue to confront, and update the public on, the IV solution shortage https://t.co/8WLltRfoP3 #Shutdown2018 #fluseason

Federal government to reopen on Jan. 23, allowing #FDA to resume all normal operations and continue fulfilling all aspects of the agency’s important public health mission: https://t.co/eul2eBpstA

RT @FDArecalls: Magno-Humphries Laboratories, Inc., Issues Voluntary Nationwide Recall of Basic Drugs Brand of Senna Laxative Due t… https://t.co/ApZ26nQhWk

A whole-hearted welcome back to our valued #FDA staff, your presence was missed and we look forward to resuming normal operations on Jan. 23: https://t.co/eul2eBpstA

@megtirrell So @megtirrell thus ends the case control study of fist bumping? Is it back to handshakes at #JPM19 ??

Today @US_FDA announced new guidance for public warnings of recalls. First in a series of policy steps we’ll take this year to further improve recall process. Read more: https://t.co/HzV3hShzUK

RT @FDAOncology: The Patient Engagement Collaborative will bring together the patient community and regulators to discuss patient en… https://t.co/4Xoh9zb8TV

FDA’s compounding policy priorities plan lays out how we'll implement key provisions of DQSA through a series of draft and final guidance documents, proposed and final rules and a revised draft MOU between the FDA and the states: https://t.co/ljI2psUpfj

One step we’re taking is to make it more feasible for certain compounders to become outsourcing facilities by taking a risk-based approach to how we will implement good manufacturing requirements with the goal of making it more practical and lower cost: h

Today, as part of our 2018 plan, FDA also issued three final guidances for compounding: two explaining the agency’s policies on the “essentially a copy” provisions and another on mixing, diluting, or repackaging biological products: https://t.co/ljI2psUpf

Today FDA issued a comprehensive plan for implementing DQSA, balancing access to compounded drugs for patients whose needs cannot be met by FDA-approved products with our obligation to help protect patients from poor quality compounded drugs: https://t.co

1/3 I recognize the consequences of a government shutdown to #FDA employees and their families. To my colleagues: You have my personal commitment that #FDA leadership will do our best to mitigate the impacts of the disruptions and any burdens to you and y

2/3 I join all of #FDA leadership in thanking the dedicated staff at #FDA during this challenging time. Key staff are working very hard this weekend to make sure mission critical, public health work will continue. I am proud to be Commissioner of this Age

3/3 If there's a shutdown Monday, I'll visit with staff at all hands at White Oak as we go through an orderly transition. Much critical work will go on. We're united w/FDA staff in support of an operational #FDA to carry out activities that support critic

I'm grateful for efforts of #FDA colleagues who remain on the job during shutdown to perform critical work to protect public; and I’m committed to do what we can to address hardship on those who find themselves on furlough as a result of lapse in funding

#ShutDown: Critical activities at #FDA related to flu will continue. Latest #FluView report indicates widespread #flu activity across the U.S.; and significant flu activity likely to continue for several more weeks. Updates: https://t.co/74SAHZZbqH

For the latest info on @FDA shutdown plans and our efforts to ensure critical activities continue during the lapse in funding, see https://t.co/xfLVvrHN4b https://t.co/eyOvPptQ3X

I’m in White Oak, MD today at #FDA headquarters. I did not travel to Davos today as previously planned

RT @PharmaPinkSheet: CBER Director Marks: #regenerativemedicine enforcement will be 'notched up' in 2018. Read in full today:… https://t.co/ptQti1ejyM

#FDA recognizes the consequences of government shutdown to public we serve, our employees and their families; thanks all for patience and dedication as legislators worked to restore funding: https://t.co/eul2eBpstA

Our drug shortage team is continuing their mission critical work. We will continue to confront, and update the public on, the IV solution shortage https://t.co/8WLltRfoP3 #Shutdown2018 #fluseason

Federal government to reopen on Jan. 23, allowing #FDA to resume all normal operations and continue fulfilling all aspects of the agency’s important public health mission: https://t.co/eul2eBpstA

RT @FDArecalls: Magno-Humphries Laboratories, Inc., Issues Voluntary Nationwide Recall of Basic Drugs Brand of Senna Laxative Due t… https://t.co/ApZ26nQhWk

A whole-hearted welcome back to our valued #FDA staff, your presence was missed and we look forward to resuming normal operations on Jan. 23: https://t.co/eul2eBpstA